NextCure, Inc. (NXTC)

NextCure Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	42	32	39	166	300	1,282
Market Cap Growth	51.37%	-18.77%	-76.37%	-44.81%	-76.57%	-
Enterprise Value	-48	-71	-114	-54	19	950
PE Ratio	-	-0.51	-0.52	-2.39	-8.20	-37.99
PS Ratio	-	-	-	-	13.42	201.94
PB Ratio	0.42	0.28	0.23	0.71	1.02	3.99
P/FCF Ratio	-1.21	-0.59	-0.70	-2.78	-5.77	-32.87
P/OCF Ratio	-1.22	-0.60	-0.73	-2.89	-6.68	-35.98
EV/Sales Ratio	-	-	-	-	0.83	149.74
EV/EBITDA Ratio	0.47	1.21	1.62	0.83	-0.56	-30.61
EV/EBIT Ratio	0.44	1.12	1.53	0.78	-0.51	-28.17
EV/FCF Ratio	0.54	1.31	2.04	0.90	-0.36	-24.37
Debt / Equity Ratio	0.06	0.05	0.04	-	0.01	0.02
Debt / EBITDA Ratio	-0.10	-0.10	-0.09	-	-0.10	-0.16
Debt / FCF Ratio	-0.11	-0.11	-0.12	-	-0.07	-0.13
Quick Ratio	10.02	15.73	17.52	33.23	27.62	22.36
Current Ratio	10.70	16.38	17.97	34.48	27.89	22.60
Asset Turnover	0	0	0	0	0.07	0.03
Return on Equity (ROE)	-53.30%	-47.00%	-39.30%	-27.10%	-11.70%	-21.80%
Return on Assets (ROA)	-47.50%	-42.60%	-37.20%	-26.00%	-11.30%	-14.70%
Return on Capital (ROIC)	-65.70%	-56.19%	-43.59%	-30.32%	-13.87%	-11.48%
Earnings Yield	-151.89%	-197.18%	-190.83%	-41.86%	-12.19%	-2.63%
FCF Yield	-122.52%	-169.11%	-143.00%	-35.98%	-17.34%	-3.04%
Buyback Yield / Dilution	-0.46%	-0.33%	-0.46%	-0.30%	-75.41%	-1045.78%
Total Shareholder Return	-0.46%	-0.33%	-0.46%	-0.30%	-75.41%	-1045.78%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).